StockData
VREXNasdaqElectronic Components, NECFiscal year ends October 2

Varex Imaging Corp

Financials through Q3 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Aug 10, 2026
$18.40−0.01 (-0.05%)

Close on Oct 19, 2026

Market cap
$783.84M
P/E (TTM)
35.4
Dividend yield
–

About Varex Imaging

Electronic Components, NEC, SIC 3679

Varex Imaging Corporation designs, manufactures, and services X-ray imaging components and specialized imaging systems. The company operates through two reportable segments: Medical and Industrial. Its Medical unit offers X-ray tubes, flat panel and photon counting detectors, connectors, and image-processing software for applications such as computed tomography and mammography. The Industrial unit supplies linear accelerators, scanners, and cargo inspection systems for security screening and non-destructive testing. Customers are primarily original equipment manufacturers, alongside independent service providers, distributors, and government agencies.

The enterprise employs around 2,400 full-time staff across engineering, manufacturing, and service facilities located in North America, Europe, and Asia. It conducts manufacturing in eight countries, including the United States, the United Kingdom, the Netherlands, Germany, Finland, the Philippines, China, and India, and maintains a regional service center in Germany. Commercial sales span three geographic regions: the Americas, EMEA, and APAC. Annually, the business produces over 27,000 X-ray tubes and 20,000 detectors. The excerpt does not state the location of its headquarters.

Summary of the business section of Varex Imaging's latest annual report, written by StockData.

Company profile

Company

Legal name
Varex Imaging Corp
Headquarters
Salt Lake City, UT
Address
1678 S. Pioneer Road 84104
Phone
(801) 972-5000
Employees
400, Oct 3, 2025
Industry
Electronic Components, NEC
Incorporated in
Delaware
Fiscal year ends
October 2
Auditor
Deloitte & Touche LLP, Salt Lake City, Utah

Stock & identifiers

Ticker
VREX
Exchange
Nasdaq
IPO date
Jan 23, 2017
Shares outstanding
42M, Aug 3, 2026
Public float
$339.30M, Apr 4, 2025
Filer category
Accelerated filer
SEC CIK
1681622
CUSIP
92214X106
ISIN
US92214X1063
LEI
549300CWYWPVCT8E9W67
EIN
81-3434516

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Sunny SanyalPresident and CEO, Director231,892
Shubham MaheshwariChief Financial Officer269,972
Karen L. ArankiChief Human Resources Officer8,893
Jesse Don MerkleySVP and GM, Industrial15,334
Victor Hugo GarciaSVP, Regulatory and QA23,360
Andrew HartmannSVP and GM, Detectors36,182
Mark S. JonaitisSVP and GM, X-Ray Sources77,341
Matthew Aaron MartinezChief Legal Officer0
Kimberley E. HoneysettSVP and CLO4,197
Jay K. KunkelDirector15,329
Jocelyn D. ChertoffDirector42,194
Christine A. TsingosDirector42,655
Timothy E. GuertinDirector26,777
Walter M. Rosebrough JrDirector52,654
Kathleen BardwellDirector12,102

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Sunny Sanyal
$4.63M$4.14M$1.39M$97$135
FY2024
Sunny Sanyal
$4.75M$1.12M$1.29M$96$128
FY2023
Sunny Sanyal
$4.52M$3.66M$1.19M$152$104
FY2022
Sunny Sanyal
$4.47M$1.17M$1.29M$171$96
FY2021
Sunny Sanyal
$4.69M$10.13M$1.22M$231$128

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“We continually invest in research and development and employ approximately 400 individuals in product development related activities.”

Corporate history

Events identified from SEC filings